Treatment of Neonatal Hemochromatosis with Exchange Transfusion and Intravenous Immunoglobulin

Journal of Pediatrics

Volumn 155, Issue 4, 2009, Pages

  Rand, Elizabeth B ^a   Karpen, Saul J ^b   Kelly, Susan ^c   Mack, Cara L ^d   Malatack, J Jeffrey ^e   Sokol, Ronald J ^d   Whitington, Peter F ^f  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c CHILDREN'S MEMORIAL HOSPITAL   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

^e NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; DEFEROXAMINE; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; PROSTAGLANDIN E1; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SELENIUM;

ARTICLE; CLINICAL ARTICLE; DRUG MEGADOSE; EXCHANGE BLOOD TRANSFUSION; FOLLOW UP; HEMOCHROMATOSIS; HUMAN; IMMUNOTHERAPY; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; PROTHROMBIN TIME; SURVIVAL; TREATMENT OUTCOME;

EID: 70249151112     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2009.04.012     Document Type: Article

References (30)

1. Knisely A.S., Mieli-Vergani G., and Whitington P.F. Neonatal hemochromatosis. Gastroenterol Clin North Am 32 (2003) 877-889
2. Murray K.F., and Kowdley K.V. Neonatal hemochromatosis. Pediatrics 108 (2001) 960-964
3. Whitington P.F. Fetal and infantile hemochromatosis. Hepatology 43 (2006) 654-660
4. Flynn D.M., Mohan N., McKiernan P., Beath S., Buckels J., Mayer D., et al. Progress in treatment and outcome for children with neonatal haemochromatosis. Arch Dis Child Fetal Neonatal Ed 88 (2003) F124-F127
5. Rodrigues F., Kallas M., Nash R., Cheeseman P., D'Antiga L., Rela M., et al. Neonatal hemochromatosis: medical treatment vs transplantation: the king's experience. Liver Transpl 11 (2005) 1417-1424
6. Sigurdsson L., Reyes J., Kocoshis S.A., Hansen T.W., Rosh J., and Knisely A.S. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gastroenterol Nutr 26 (1998) 85-89
7. Sundaram S.S., Alonso E.M., and Whitington P.F. Liver transplantation in neonates. Liver Transpl 9 (2003) 783-788
8. Whitington P.F. Neonatal hemochromatosis: a congenital alloimmune hepatitis. Semin Liver Dis 27 (2007) 243-250
9. Kelly A.L., Lunt P.W., Rodrigues F., Berry P.J., Flynn D.M., McKiernan P.J., et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 38 (2001) 599-610
10. Whitington P.F., and Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 121 (2008) e1615-e1621
11. Whitington P.F., and Hibbard J.U. High-dose immunoglobulin during pregnancy for recurrent neonatal haemochromatosis. Lancet 364 (2004) 1690-1698
12. Durand P., Debray D., Mandel R., Baujard C., Branchereau S., Gauthier F., et al. Acute liver failure in infancy: a 14-year experience of a pediatric liver transplantation center. J Pediatr 139 (2001) 871-876
13. Grabhorn E., Richter A., Burdelski M., Rogiers X., and Ganschow R. Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics 118 (2006) 2060-2065
14. Heffron T., Pillen T., Welch D., Asolati M., Smallwood G., Hagedorn P., et al. Medical and surgical treatment of neonatal hemochromatosis: single center experience. Pediatr Transplant 11 (2007) 374-378
15. Squires Jr. R.H., Shneider B.L., Bucuvalas J., Alonso E., Sokol R.J., Narkewicz M.R., et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148 (2006) 652-658
16. Hayes A.M., Jaramillo D., Levy H.L., and Knisely A.S. Neonatal hemochromatosis: diagnosis with MR imaging. AJR Am J Roentgenol 159 (1992) 623-625
17. Udell I.W., Barshes N.R., Voloyiannis T., Lee T.C., Karpen S.J., Carter B.A., et al. Neonatal hemochromatosis: radiographical and histological signs. Liver Transpl 11 (2005) 998-1000
18. Knisely A.S., O'Shea P.A., Stocks J.F., and Dimmick J.E. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 113 (1988) 871-874
19. Smith S.R., Shneider B.L., Magid M., Martin G., and Rothschild M. Minor salivary gland biopsy in neonatal hemochromatosis. Arch Otolaryngol Head Neck Surg 130 (2004) 760-763
20. Varani J., Dame M.K., Diaz M., and Stoolman L. Deferoxamine interferes with adhesive functions of activated human neutrophils. Shock 5 (1996) 395-401
21. Shamieh I., Kibort P.K., Suchy F.J., and Freese D.K. Antioxidant therapy for neonatal iron storage disease (NISD). Abstract. Pediatr Res 33 (1993) 109A
22. Vohra P., Haller C., Emre S., Magid M., Holzman I., Ye M.Q., et al. Neonatal hemochromatosis: the importance of early recognition of liver failure. J Pediatr 136 (2000) 537-541
23. Leonis M.A., and Balistreri W.F. Neonatal hemochromatosis: it's OK to say "NO" to antioxidant-chelator therapy. Liver Transpl 11 (2005) 1323-1325
24. Kortsalioudaki C., Taylor R.M., Cheeseman P., Bansal S., Mieli-Vergani G., and Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure. Liver Transpl 14 (2008) 25-30
25. Lee W.Y., and Lee S.M. Protective effects of alpha-tocopherol and ischemic preconditioning on hepatic reperfusion injury. Arch Pharm Res 28 (2005) 1392-1399
26. Kazatchkine M.D., and Kaveri S.V. Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345 (2001) 747-755
27. Arredondo J., Chernyavsky A.I., Karaouni A., and Grando S.A. Novel mechanisms of target cell death and survival and of therapeutic action of IVIg in Pemphigus. Am J Pathol 167 (2005) 1531-1544
28. Silver M.M., Valberg L.S., Cutz E., Lines L.D., and Phillips M.J. Hepatic morphology and iron quantitation in perinatal hemochromatosis: comparison with a large perinatal control population, including cases with chronic liver disease. Am J Pathol 143 (1993) 1312-1325
29. Bernuau J., Rueff B., and Benhamou J.P. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6 (1986) 97-106
30. Tha-In T., Metselaar H.J., Tilanus H.W., Boor P.P., Mancham S., Kuipers E.J., et al. Superior immunomodulatory effects of intravenous immunoglobulins on human T-cells and dendritic cells: comparison to calcineurin inhibitors. Transplantation 81 (2006) 1725-1734